William E. Carson mainly focuses on Immunology, Interleukin 21, Interleukin 12, Immune system and Natural killer cell. His Immunology study combines topics from a wide range of disciplines, such as Lymphopoiesis, Cancer, Breast cancer and Stromal cell. His Interleukin 21 research is multidisciplinary, incorporating perspectives in Molecular biology and Interleukin 15.
The Interleukin 12 study combines topics in areas such as Chemokine, Innate immune system and Cytokine, Interferon gamma. The concepts of his Immune system study are interwoven with issues in Cancer research and Myeloid-derived Suppressor Cell. The various areas that William E. Carson examines in his Natural killer cell study include Tumor necrosis factor alpha and Natural killer T cell.
William E. Carson spends much of his time researching Cancer research, Immunology, Internal medicine, Immune system and Cancer. His Cancer research study combines topics from a wide range of disciplines, such as Tumor microenvironment, Apoptosis, Signal transduction and Alpha interferon. The concepts of his Immunology study are interwoven with issues in Interleukin 12 and Peripheral blood mononuclear cell.
In his research, Cetuximab and Disease is intimately related to Oncology, which falls under the overarching field of Internal medicine. His studies deal with areas such as Cancer cell, Myeloid and Myeloid-derived Suppressor Cell as well as Immune system. His research investigates the connection between Interleukin 21 and topics such as Molecular biology that intersect with problems in Interleukin 15.
His main research concerns Cancer research, Internal medicine, Cancer, Immune system and Oncology. William E. Carson is studying Melanoma, which is a component of Cancer research. His Cancer research includes themes of Colony stimulating factor 1 receptor, Innate immune system, Cutaneous melanoma and BRD4.
He combines subjects such as Suppressor, Peripheral blood mononuclear cell, Equol and Cytokine with his study of Immune system. His work on Adjuvant as part of general Oncology research is frequently linked to Weight gain, bridging the gap between disciplines. His Myeloid-derived Suppressor Cell study also includes
William E. Carson mainly investigates Cancer research, Internal medicine, Cancer, Inflammation and Gene mutation. His Cancer research research is multidisciplinary, relying on both Cell, Epidermal growth factor receptor, Tumor microenvironment, Ibrutinib and Bruton's tyrosine kinase. In his work, Cytokine is strongly intertwined with In vivo, which is a subfield of Tumor microenvironment.
His Internal medicine study frequently involves adjacent topics like Oncology. William E. Carson has researched Oncology in several fields, including Interleukin 12, Disease and Cutaneous melanoma. When carried out as part of a general Cancer research project, his work on Carcinogenesis is frequently linked to work in Giant Cell Tumors, therefore connecting diverse disciplines of study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset
Megan A. Cooper;Todd A. Fehniger;Sarah C. Turner;Kenneth S. Chen.
Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.
William E. Carson;Judith G. Giri;Matthew J. Lindemann;Michael L. Linett.
Journal of Experimental Medicine (1994)
Psychological, Behavioral, and Immune Changes After a Psychological Intervention: A Clinical Trial
Barbara L. Andersen;William B. Farrar;Deanna M. Golden-Kreutz;Ronald Glaser.
Journal of Clinical Oncology (2004)
Psychologic Intervention Improves Survival for Breast Cancer Patients: A Randomized Clinical Trial
Barbara L. Andersen;Hae-Chung Yang;William B. Farrar;Deanna M. Golden-Kreutz.
A potential role for interleukin-15 in the regulation of human natural killer cell survival.
W E Carson;T A Fehniger;S Haldar;K Eckhert.
Journal of Clinical Investigation (1997)
Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro.
William E. Carson;Mary E. Ross;Robert A. Baiocchi;Melanie J. Marien.
Journal of Clinical Investigation (1995)
Cutaneous melanoma, version 2.2019
Daniel G. Coit;John A. Thompson;Mark R. Albertini;Christopher Barker.
Journal of The National Comprehensive Cancer Network (2019)
Myeloid derived suppressor cells – a new therapeutic target in the treatment of cancer
Robert Wesolowski;Joseph Markowitz;William E Carson.
Journal for ImmunoTherapy of Cancer (2013)
Pain, depression, and fatigue: loneliness as a longitudinal risk factor.
Lisa M. Jaremka;Rebecca R. Andridge;Christopher P. Fagundes;Catherine M. Alfano.
Health Psychology (2014)
Flt3 Ligand Promotes the Generation of a Distinct CD34+Human Natural Killer Cell Progenitor That Responds to Interleukin-15
Haixin Yu;Todd A. Fehniger;Todd A. Fehniger;Todd A. Fehniger;Pascal Fuchshuber;Pascal Fuchshuber;Pascal Fuchshuber;Karl S. Thiel;Karl S. Thiel;Karl S. Thiel.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: